A detailed history of R.M.Sincerbeaux Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, R.M.Sincerbeaux Capital Management LLC holds 45,000 shares of PFE stock, worth $1.13 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
45,000
Previous 44,700 0.67%
Holding current value
$1.13 Million
Previous $1.25 Million 4.16%
% of portfolio
0.81%
Previous 0.83%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $8,310 - $9,417
300 Added 0.67%
45,000 $1.3 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $217,236 - $254,560
-8,600 Reduced 16.14%
44,700 $1.25 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $64,725 - $74,325
-2,500 Reduced 4.48%
53,300 $1.48 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $385,080 - $450,120
-12,000 Reduced 17.7%
55,800 $1.85 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $66,725 - $85,714
-1,700 Reduced 2.45%
67,800 $2.92 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $10,772 - $12,204
-300 Reduced 0.43%
69,500 $2.72 Million
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $134,576 - $152,727
-4,088 Reduced 5.53%
69,800 $2.74 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $54,843 - $71,115
1,688 Added 2.34%
73,888 $2.66 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $62,422 - $70,085
-1,688 Reduced 2.28%
72,200 $0
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $65,564 - $69,898
1,988 Added 2.76%
73,888 $2.68 Million
Q2 2017

Aug 10, 2017

BUY
N/A
71,900
71,900 $2.42 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track R.M.Sincerbeaux Capital Management LLC Portfolio

Follow R.M.Sincerbeaux Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R.M.Sincerbeaux Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on R.M.Sincerbeaux Capital Management LLC with notifications on news.